Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna, Inc. (MRNA), headquartered in Cambridge, Massachusetts, is a leading biotechnology company committed to pioneering messenger RNA (mRNA) therapeutics and vaccines to transform the future of ...

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal sales" in 2024. Analysts' concerns were heightened by the company's revised ...

Editor's note: This article was updated at 500p ET with information from a Moderna ... the drugmaker in July to develop a bird flu vaccine. Moderna noted that the new funding will support the ...

The study included vaccine candidates against H5 and ... impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly ...

Representatives of Moderna Biotech UK and NHS England will also be questioned by the inquiry, led by crossbench peer Baroness Hallett.

For more information about Moderna ... the opportunity and potential for up to 17 participating countries to order COVID-19 vaccines from Moderna over a four-year period; and healthcare provider ...

Coming up: We think Moderna will be able to supplement its current portfolio with a next-generation covid vaccine and broader ... How we use your information depends on the product and service ...

For more information about Moderna ... and potential for up to 17 participating countries to order COVID-19 vaccines from Moderna over a four-year period; and healthcare provider preferences ...